glp 1 nafld Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Pathophysiological mechanisms involved in the

Will adding L-carnitine supplement make tirzepatide work faster

Room temperature represents just one option on a spectrum from frozen storage to elevated temperature stress

Oxidative stress in neurodegenerative diseases

de Azevedo AA, Figueiredo RR

One of the most interesting dynamics with GLP-1s is that coverage expansion appears to be occurring despite major budget concerns because payers and employers are increasingly evaluating obesity through a broader long-term outcomes and healthcare cost lens rather than as an isolated pharmacy spend category

Western blot analysis revealed that FSN, TSA, and PDTC all inhibited the protein expression of p65, P-p65, HDAC1, and HDAC2